Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
heart save search
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG
Published: 2024-04-24 (Crawled : 13:00) - globenewswire.com
HSCS | $0.1096 10.82% 28M
|
n/a
|
| O: 18.3%
H: 0.0%
C: 0.0%
patent grant heart
HeartCore Expands Partnership with Heart-Tech Health
Published: 2024-04-22 (Crawled : 13:00) - globenewswire.com
HTCR | News | $0.96 18K
|
|
| O: -7.07%
H: 7.61%
C: 1.09%
partnership health
New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion
Published: 2024-04-16 (Crawled : 12:00) - globenewswire.com
DXR | $9.8 860
|
Health Technology
|
| O: 0.53%
H: 1.99%
C: 0.0%
bva-100 diagnostic blood for heart benefits
QuickLogic to Showcase FPGA/eFPGA Expertise at HEART Conference
Published: 2024-04-11 (Crawled : 18:00) - prnewswire.com
QUIK | $12.36 0.65% 130K
|
Electronic Technology
|
| O: -0.72%
H: 0.0%
C: -4.58%
conference heart
Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
Published: 2024-04-10 (Crawled : 12:00) - globenewswire.com
CYTK | $66.935 2.08% 370K
|
Health Technology
|
| O: -3.34%
H: 3.39%
C: 2.51%
congress heart trial cardiology
CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting
Published: 2024-04-09 (Crawled : 13:00) - biospace.com/
CDNA | $8.075 -1.88% 170K
|
Health Technology
|
| O: 0.63%
H: 5.84%
C: 3.75%
lung international for meeting heart
iCAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting
Published: 2024-04-08 (Crawled : 21:00) - globenewswire.com
ICAD | $1.56 16K
|
Technology Services
|
| O: 5.7%
H: 11.98%
C: 7.78%
disease risk meeting heart cardiology
Natera Announces New Data From Two Studies Extending the Clinical Validation of Its Prospera™ Heart dd-cfDNA Test for Heart Transplant Recipients
Published: 2024-04-08 (Crawled : 13:30) - biospace.com/
NTRA | News M | $92.44 1.54% 390K
|
Health Services
|
| O: 0.92%
H: 0.26%
C: -2.26%
test for heart
New survey uncovers lack of awareness around heart valve disease and risk factors among women
Published: 2024-04-07 (Crawled : 12:20) - prnewswire.com
MDT | $80.37 -1.13% 2.6M
|
Health Technology
| Email alert
Add to watchlist
disease risk women heart
HeartSciences to Present at the LD Micro Invitational XIV Conference
Published: 2024-04-02 (Crawled : 20:00) - globenewswire.com
HSCS | $0.1096 10.82% 28M
|
n/a
|
| O: 3.05%
H: 0.46%
C: -2.13%
conference
Abbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve
Published: 2024-04-02 (Crawled : 15:30) - biospace.com/
ABT | News | $106.96 -0.59% 2.6M
|
Health Technology
|
| O: -0.18%
H: 0.47%
C: 0.12%
fda device approval heart
Milestone® Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and European Heart Rhythm Association Annual Conferences
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
MIST | $1.645 -3.24% 30K
|
Health Technology
|
| O: -5.32%
H: 2.81%
C: 2.81%
milestone etripamil association pharmaceuticals heart cardiology
Beyond Meat® Unveils New and Expanded Line of Beyond Crumbles, Now Certified by the American Heart Association’s Heart-Check Program and the American Diabetes Association’s Better Choices for Life Program
Published: 2024-03-28 (Crawled : 13:00) - globenewswire.com
BYND F | $6.05 -0.33% 1.2M
|
Consumer Non-Durables
|
| O: 1.69%
H: 2.97%
C: -1.78%
meat beyond life certified heart program diabetes
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
Published: 2024-03-26 (Crawled : 13:00) - globenewswire.com
HSCS | $0.1096 10.82% 28M
|
n/a
|
| O: 2.5%
H: 0.0%
C: -2.52%
myovista congress world presentation
Tectonic Therapeutic Initiates Phase 1B Study for TX45 in Group 2 Pulmonary Hypertension in Patients with Preserved Ejection Fraction Heart Failure
Published: 2024-03-26 (Crawled : 12:00) - biospace.com/
AVRO | $1.2 -0.83% 240K
|
Health Technology
|
| O: 2.46%
H: 1.6%
C: 0.8%
tx45 group hypertension heart study
Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo
Published: 2024-03-25 (Crawled : 13:00) - globenewswire.com
LXRX | $1.61 1.2M
|
Health Technology
|
| O: 0.0%
H: 4.2%
C: -6.19%
stroke risk expo impact heart cardiology
TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting
Published: 2024-03-25 (Crawled : 13:00) - globenewswire.com
TFFP | $3.04 2.36% 8.6K
|
Health Technology
|
| O: 0.13%
H: 3.77%
C: -3.9%
lung tacrolimus presentation international pharmaceuticals meeting heart study
U.S. FDA Approves Broad New Labels for NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use
Published: 2024-03-22 (Crawled : 19:00) - globenewswire.com
ESPR | $2.125 1.68% 4M
|
Health Technology
| Email alert
Add to watchlist
nexletol fda heart cardiovascular
Ferinject® approved by Health Canada for the treatment of iron deficiency anemia in adult and pediatric patients and iron deficiency in adult patients with heart failure
Published: 2024-03-19 (Crawled : 11:00) - prnewswire.com
TVTX | $5.405 -5.84% 390K
|
Health Technology
|
| O: -0.7%
H: 5.47%
C: 4.91%
ferinject health anemia approved treatment canada heart
HeartSciences Reports Third Quarter Fiscal 2024 Financial Results
Published: 2024-03-14 (Crawled : 20:00) - globenewswire.com
HSCS | $0.1096 10.82% 28M
|
n/a
|
| O: 0.8%
H: 7.06%
C: 0.56%
financial results
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.88 60.68% 98M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.85 51.79% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
SKIL 4 | $8.045 40.89% 230K
|
Information
MULN | News | $3.805 39.38% 11M
|
Information
RILY | $30.01 38.17% 11M
|
Finance
MTC | $3.04 35.71% 6.7M
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.